Infectious Diseases News and Research

RSS

UTMB researchers develop less expensive way to produce vaccines

Researchers at The University of Texas Medical Branch at Galveston have developed less expensive way to produce vaccines that cuts the costs of vaccine production and storage by up to 80 percent without decreasing safety or effectiveness.

6 Oct 2018

Simple cleaning procedure reduces MRSA transmission from therapy dogs to children with cancer

Therapy dogs help ease stress in young patients with cancer, but can spread methicillin-resistant Staphylococcus aureus, putting vulnerable kids at risk for a serious infection.

5 Oct 2018

Krembil scientists develop potential treatment to stop knee and spine osteoarthritis

Scientists at the Krembil Research Institute have developed a novel therapeutic treatment that has the potential to stop knee and spine osteoarthritis in its tracks.

5 Oct 2018

UConn chemists develop new antibiotic that can find and kill tuberculosis bacteria

Tuberculosis is a sneaky disease. The bacteria hide from antibiotics inside the very immune cells that are supposed to kill them, making treatment long and difficult. But in the November issue of ACS Infectious Diseases, UConn chemists report a new antibiotic that can find and kill tuberculosis bacteria where they hide.

4 Oct 2018

Australia will soon become the first country to eradicate cervical cancer

According to an announcement from the International Papillomavirus Society, Australia could soon become the first country to eradicate cervical cancer.

4 Oct 2018

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

The married professors were spending their Thanksgiving holiday in Egypt when the husband, Thomas L. Patterson, Ph.D., got very sick very quickly, experiencing fever, nausea and a racing heartbeat. By the time Patterson was accurately diagnosed with a highly multi-drug resistant bacterial infection, he was near death.

4 Oct 2018

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

Genentech, a member of the Roche Group, today announced that the Phase III CAPSTONE-2 study showed treatment with baloxavir marboxil significantly reduced the time to improvement of influenza symptoms versus placebo in people at high risk of serious complications from the flu, which includes adults 65 years of age or older, or those who have conditions such as asthma, chronic lung disease, morbid obesity, or heart disease.

4 Oct 2018

New ReFRAME drug repurposing collection offers hope for treating major diseases

Each year, millions of people worldwide suffer from potentially fatal infectious diseases that often leave survivors facing a lifetime of related health problems. But what if drugs against such diseases already existed but nobody knew it?

4 Oct 2018

Special glowing paper strip as rapid, reliable test for infectious diseases

Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) present a practicable and reliable way to test for infectious diseases.

3 Oct 2018

Penn scientists to explore new approach for predicting and treating diseases at individual level

A new National Institutes of Health High-Risk, High-Reward grant will allow Penn State's Steven Schiff and team to explore a radically changed approach to predicting, preventing and treating infectious disease at the individual level at point-of-care.

3 Oct 2018

Immune protein 'flutters' like a butterfly in search of viruses, finds study

Researchers at Rutgers Robert Wood Johnson Medical School have identified an important step in the process that allows our bodies to fight viruses.

2 Oct 2018

HyFly research project aims to break chains of infection and prevent pandemics

Global air travel isn't restricted to people and goods - infectious agents, too, can make their way on board as unwelcome passengers and travel great distances within a matter of hours.

1 Oct 2018

Scientists investigate effect of flu-causing virus on three lung-derived cell lines

Perhaps inspired by the annual 3 to 5 million cases of severe influenza worldwide, the Guinness World Record organization is advertising for individuals or organizations to attempt a record for the most people getting a flu awareness lesson at once.

29 Sep 2018

Geoengineering still lacks a ‘clean bill of health’

Radical solutions to climate change might save lives, but a commentary in the October 2018 issue of the journal Nature Climate Change calls for caution because geoengineering still lacks a "clean bill of health."

29 Sep 2018

The Friedrich Schiller University Jena receives funding for Cluster of Excellence

The Friedrich Schiller University Jena (Germany) was granted funding for one Cluster of Excellence. As the Excellence Commission announced today in Bonn, Jena's proposal for the cluster 'Balance of the Microverse' is among the 57 selected consortia which will be funded by the German Excellence Strategy for the following seven years.

28 Sep 2018

Broadly neutralizing antibodies offer a new approach to treating HIV infection

A new generation of broadly neutralizing antibodies provides a novel approach to treating HIV infection.

28 Sep 2018

Study aims to investigate antimicrobial resistance of uropathogenic E. coli from elderly patients

Urinary Tract Infection is a common cause of morbidity and mortality in older adults. Escherichia coli is one of the bacterial agents with higher prevalence in community-acquired and health care associated urinary infections in elderly patients.

27 Sep 2018

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

Fina Biosolutions announces that the United States Patent and Trademark Office has issued a patent for expression and purification of the conjugate vaccine protein CRM197 in E. coli.

27 Sep 2018

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

The Global Antibiotic Research & Development Partnership and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children in low- and middle-income countries.

27 Sep 2018

Auto-FMT found to be safe, effective way to replenish beneficial gut bacteria in cancer patients

Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation.

27 Sep 2018

Infectious Diseases News and Research

UTMB researchers develop less expensive way to produce vaccines

Simple cleaning procedure reduces MRSA transmission from therapy dogs to children with cancer

Krembil scientists develop potential treatment to stop knee and spine osteoarthritis

UConn chemists develop new antibiotic that can find and kill tuberculosis bacteria

Australia will soon become the first country to eradicate cervical cancer

Doctors use bacteriophages to treat patient with multi-drug resistant bacterial infection

Genentech announces Phase III study results of baloxavir marboxil in people at high risk of flu

New ReFRAME drug repurposing collection offers hope for treating major diseases

Special glowing paper strip as rapid, reliable test for infectious diseases

Penn scientists to explore new approach for predicting and treating diseases at individual level

Immune protein 'flutters' like a butterfly in search of viruses, finds study

HyFly research project aims to break chains of infection and prevent pandemics

Scientists investigate effect of flu-causing virus on three lung-derived cell lines

Geoengineering still lacks a ‘clean bill of health’

The Friedrich Schiller University Jena receives funding for Cluster of Excellence

Broadly neutralizing antibodies offer a new approach to treating HIV infection

Study aims to investigate antimicrobial resistance of uropathogenic E. coli from elderly patients

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

Auto-FMT found to be safe, effective way to replenish beneficial gut bacteria in cancer patients

NGS for Infectious Disease Surveillance eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News